EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ferroptosis‐Driven Neuronal Damage Exacerbation in Diabetic Stroke: Implications of SLC7A11 Inhibition

Siyuan Liu, Min Liu, Binbin Wang, Miao Sun, Huikai Yang, Mengyao Qu, Libin Ma, Likai Shi, Yuxiang Song, Peng Li, Lulu Zhou, Wugang Hou und 2 weitere

CNS Neuroscience & Therapeutics · 2026-03 · 32 (3)

DOI: 10.1002/cns.70830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 12.03.2026. Verfasst von Siyuan Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Affiliated Hospital of Nantong University, Nantong, China. Hauptthemen laut MEDLINE: Ferroptosis, Neurons, Amino Acid Transport System y+, Stroke. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing, Jiangsu Provincial Research Hospital Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetes mellitus is a known contributor to worsened neurological outcomes following ischemic stroke, yet the underlying mechanisms remain elusive. Emerging evidence links ferroptosis to the extent of neuronal damage postischemic stroke. However, the role of ferroptosis in the context of diabetic stroke remains uncharted. SLC7A11, a key player in cellular antioxidant defense and ferroptosis regulation, has unexplored functions in diabetic cerebral ischemia/reperfusion.

Methods

In this study, we employed leptin receptor deficient (db/db) mice and wild‐type (WT) littermates to model cerebral ischemic stroke. We harnessed quantitative proteomics to identify differentially expressed proteins and uncover potential signaling pathways. Infarct volume was assessed via 2,3,5‐triphenyltetrazolium chloride staining. Neurobehavioral tests, immunohistochemistry, and immunofluorescence staining were employed to evaluate neuronal injury. The expression of SLC7A11 was assessed using Western blot and immunofluorescence staining. Dihydroethidium staining, flow cytometry, immunofluorescence staining, transmission electron microscopy, immunohistochemistry, and ELISA were used to assess ferroptosis. Furthermore, an adeno‐associated viral 9 (AAV9) vector encoding SLC7A11 was utilized to validate the protective potential of neuronal SLC7A11 overexpression during diabetic stroke.

Results

Diabetic stroke mice exhibited exacerbated cerebral injury, with differentially expressed proteins notably enriched in ferroptosis. Ferroptosis inhibitors markedly ameliorated neuronal damage in diabetic stroke mice. Additionally, we uncovered inhibited SLC7A11 expression and heightened ferroptosis in the early stages of reperfusion during diabetic stroke. Neuron‐specific enforced expression of SLC7A11 mitigated neuronal lipid peroxidation and ferroptosis, providing neuroprotective effects against diabetic cerebral ischemic injury. These protective effects were underscored by the decreased infarct volume, enhanced neurological function, and increased neuronal survival.

Conclusion

Our study points to SLC7A11 inhibition‐mediated ferroptosis as a pivotal factor in the aggravated neuronal damage observed during diabetic stroke. This novel insight opens avenues for potential therapeutic targets in the management of diabetic stroke, focusing on interventions aimed at modulating ferroptosis or SLC7A11 expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisNeuronsAmino Acid Transport System y+StrokeIschemic StrokeDiabetes Mellitus, ExperimentalAnimalsMiceMaleMice, Inbred C57BLReceptors, Leptin

Stichwörter der Autor:innen

SLC7A11diabetes mellitusferroptosisischemic stroke

Substanzen

Slc7a11 protein, mouseAmino Acid Transport System y+Receptors, Leptin

Autor:innen und Institutionen

  • Department of Anesthesiology, Affiliated Hospital of Nantong University, Nantong, China.
  • Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
  • Department of Anesthesiology, The Sixth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Department of Oncology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning Province, China.

ORCID-Profile: Weidong Mi, Yulong Ma

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing
  • Jiangsu Provincial Research Hospital Fund
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Liu, S., Liu, M., Wang, B., Sun, M., Yang, H., Qu, M., Ma, L., Shi, L., Song, Y., Li, P., Zhou, L., Hou, W., Mi, W., & Ma, Y. (2026). Ferroptosis‐Driven Neuronal Damage Exacerbation in Diabetic Stroke: Implications of SLC7A11 Inhibition. CNS Neuroscience & Therapeutics, 32(3). https://doi.org/10.1002/cns.70830

Vancouver

Liu S, Liu M, Wang B, Sun M, Yang H, Qu M, et al. Ferroptosis‐Driven Neuronal Damage Exacerbation in Diabetic Stroke: Implications of SLC7A11 Inhibition. CNS Neuroscience & Therapeutics. 2026;32(3). doi:10.1002/cns.70830

BibTeX
@article{Liu2026,
  author = {Liu, Siyuan and Liu, Min and Wang, Binbin and Sun, Miao and Yang, Huikai and Qu, Mengyao and Ma, Libin and Shi, Likai and Song, Yuxiang and Li, Peng and Zhou, Lulu and Hou, Wugang and Mi, Weidong and Ma, Yulong},
  title = {Ferroptosis‐Driven Neuronal Damage Exacerbation in Diabetic Stroke: Implications of SLC7A11 Inhibition},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {3},
  doi = {10.1002/cns.70830}
}
Kostenlos starten →